| 5 | 1/1 | 返回列表 |
| 查看: 913 | 回復(fù): 8 | |||
| 當(dāng)前只顯示滿足指定條件的回帖,點(diǎn)擊這里查看本話題的所有回帖 | |||
tzkcarlos銀蟲 (小有名氣)
|
[求助]
自身免疫學(xué)翻譯為中文-幾段話,Autoimmunity Reviews 13 (2014) 108–113
|
||
|
PLA 2 R1 is a type 1 transmembrane receptor that is expressed by podocytes. Besides a short membrane-spanning intracellular domain, the receptor consists of a long extracellular domain with a cysteine-rich head, a fibronectin type II-like repeat domain and eight repeated carbohydrate-recognition domains [22]. PLA 2 R1 is one of four members of the mannose receptor family [23]. All of them have a conserved domain structure and share common characteristics such as constitutive endocytic recycling at the plasma membrane [24] which may provide a constant source of accessible PLA 2 R1 at the podocyte membrane for immune-complex formation [23]. Further more, the receptors exist in both an extended and a bent conformation conferring distinct ligand binding and oligomerization capacities [25]. Since the anti-PLA 2 R1 autoantibodies in patients with pMN only recognize a conformation-dependent target epitope [21], it is assumed that autoantibody-binding might only occur in one of these two configurations. Therefore, pMN might represent an autoimmune conformational disease (‘conformeropathy’), such as Goodpasture syndrome [1]. Although the exact mechanisms causing pMN are still under investigation, different studies show a strong relationship between antibody levels to podocytic proteins and disease activity. Since the discovery of anti-PLA 2 R1 autoantibodies by Beck et al. in 2009, there has been strong evidence that they are a key player in the pathogenesis [21]. For example, autoantibodies to PLA 2 R1 can not only be eluted from kidney tissue of pMN patients, but also colocalize with PLA 2 R1 in the glomeruli [21]. Therefore, it is widely accepted that upon binding of circulating autoantibodies to PLA 2 R1 on podocytes, subepithelial deposits are formed in situ, leading to complement activation and a cascade of events subsequent to the nephrotic syndrome (in most of the cases) [37]. Interestingly, autoantibodies to PLA 2 R1 have shown to be mainly of the IgG4 subclass, which is regarded as being unable to activate the complement pathway [38,39]. Nevertheless, since the terminal complement compo- nent C5b-9 is detectable in glomeruli and urine of pMN patients [40,41], there is strong evidence for the involvement of the complement system. As most patients with MN have low or undetectable levels of C1q, the classical complement pathway can be excluded. Therefore, either the alternative or the lectin pathway seems to be predominantly involved [42]. This hypothesis is supported by the notion, that mannose binding lectin can be detected in glomeruli of MN patients [43]. |
銀蟲 (小有名氣)
|
不是要求信雅達(dá),但是有些句子不大通順的情況下,我只是希望回答者再認(rèn)真檢查,看看其他有沒有問題,順便再修飾一下。如果要求很過分的話,自我檢討。至于說我一再挑剔,我想請問,回答者好像就回答了一次,我只是不斷請求他再檢查修飾,因?yàn)檫@個翻譯很重要,但他覺得不用再修改。我也不是說不給他發(fā)金幣,至于斑竹扣發(fā)30金幣,再刪除他的回答,相當(dāng)于罰我30金幣的做法,我不敢茍同。謝謝 |
至尊木蟲 (知名作家)
Translator and Proofreader
本樓樓主要求刪除![]() 我覺得他花了不少時間和心思的,樓主卻一再挑剔,有點(diǎn)過分哦。 ![]() 英文這種東西畢竟不是咱中國人的,翻譯過來難免變味,我們理工科的學(xué)生也不是學(xué)文學(xué)的,要達(dá)到“信、達(dá)、雅”也有點(diǎn)難哦。 樓主為何不參照應(yīng)助者提供的信息自己修飾一下呢? |
銀蟲 (小有名氣)
至尊木蟲 (知名作家)
Translator and Proofreader
| 最具人氣熱帖推薦 [查看全部] | 作者 | 回/看 | 最后發(fā)表 | |
|---|---|---|---|---|
|
[考研] 0703化學(xué)321分求調(diào)劑 +3 | 三dd. 2026-03-30 | 4/200 |
|
|---|---|---|---|---|
|
[考研] 317分 一志愿南理工材料工程 本科湖工大 求調(diào)劑 +11 | 芋泥小鈴鐺 2026-03-28 | 11/550 |
|
|
[考研] 279求調(diào)劑 +6 | j的立方 2026-03-29 | 6/300 |
|
|
[考研] 求化學(xué)調(diào)劑 +11 | wulanna 2026-03-28 | 11/550 |
|
|
[考研] 348求調(diào)劑 +6 | 小懶蟲不懶了 2026-03-28 | 6/300 |
|
|
[考研] 085600 286分 材料求調(diào)劑 +10 | 麻辣魷魚 2026-03-27 | 11/550 |
|
|
[考研] 考研調(diào)劑 +7 | 小蠟新筆 2026-03-29 | 7/350 |
|
|
[考研] 08工科求調(diào)劑286 +3 | tgs_001 2026-03-28 | 3/150 |
|
|
[考研] 一志愿南昌大學(xué)324求調(diào)劑 +5 | hanamiko 2026-03-29 | 5/250 |
|
|
[考研] 環(huán)境工程 085701,267求調(diào)劑 +6 | minht 2026-03-29 | 6/300 |
|
|
[考研] 295材料工程專碩求調(diào)劑 +7 | 1428151015 2026-03-27 | 7/350 |
|
|
[考研] 復(fù)試調(diào)劑 +3 | raojunqi0129 2026-03-28 | 3/150 |
|
|
[考研] 283求調(diào)劑 +7 | A child 2026-03-28 | 7/350 |
|
|
[考研] 265求調(diào)劑 +8 | 小木蟲085600 2026-03-27 | 8/400 |
|
|
[考研] 070300化學(xué)求調(diào)劑 +4 | 起個名咋這么難 2026-03-27 | 4/200 |
|
|
[考研] 322求調(diào)劑 +4 | 我真的很想學(xué)習(xí) 2026-03-23 | 4/200 |
|
|
[考研] 315調(diào)劑 +4 | 0860求調(diào)劑 2026-03-26 | 5/250 |
|
|
[考研] 材料考研求調(diào)劑 +3 | Dendel 2026-03-23 | 6/300 |
|
|
[考研] 材料科學(xué)與工程 317求調(diào)劑 +4 | JKSOIID 2026-03-26 | 4/200 |
|
|
[考研] 一志愿天津大學(xué)339材料與化工求調(diào)劑 +3 | 江往賣魚 2026-03-26 | 3/150 |
|